Alzheimer's disease.

@article{Querfurth2010AlzheimersD,
  title={Alzheimer's disease.},
  author={Henry W. Querfurth and Frank M LaFerla},
  journal={The New England journal of medicine},
  year={2010},
  volume={362 4},
  pages={
          329-44
        }
}
From the Department of Neurology, Caritas St. Elizabeth’s Medical Center, Brighton, MA (H.W.Q.); the Department of Neurology, Tufts Medical Center, Boston (H.W.Q.); the Department of Neurology, Rhode Island Hospital and the Warren Alpert Medical School at Brown University, Providence (H.W.Q.); and the Department of Neurobiology and Behavior, University of California, Irvine, Irvine (F.M.L.). Address reprint requests to Dr. Querfurth at the Department of Neurology, Rhode Island Hospital, 563… 

Figures from this paper

Is Alzheimer’s Disease a Liver Disease of the Brain?

TLDR
Evidence is presented suggesting that the liver is the origin of brain Aβ deposits and that it is involved in peripheral clearance of circulating Aβ in the blood, which means the liver could be targeted to decrease Aβ production or increase peripheral clearance.

Age related changes in cerebrovascular reactivity and its relationship to global brain structure.

TLDR
This study aims to demonstrate the importance of knowing the carrier and removal status of canine coronavirus in the diagnosis and treatment of Alzheimer’s disease.

Alzheimer's Disease: A Clinical and Basic Science Review

TLDR
Clinical and neurobiological aspects of AD and MCI that medical students should be familiar with are emphasized and advances in the use of biomarkers for diagnosis of AD are described.

PET Neuroimaging of Alzheimer's Disease: Radiotracers and Their Utility in Clinical Research

TLDR
The various PET radiotracers available for AD imaging are surveyed and discussed and their clinical applications especially in terms of early detection and cognitive relevance are discussed.

Early diagnosis and treatment of Alzheimer’s disease: new definitions and challenges

TLDR
From updated classifications and recommendations to advances in biomarkers of AD, this article aims to critically assess the literature on AD, addressing new definitions and challenges that emerged from recent studies on the subject.

New diagnostic criteria for Alzheimer ’ s disease

TLDR
Criteria for the diagnosis of probable Alzheimer’s dementia have been based on the National Institute on Aging and the Alzheimer's Association diagnostic criteria from 2011 andDSM-5 criteria from 2013, and they appear to have similar accuracy in clinical practice.

Alzheimer's disease.

Ocular Manifestations of Alzheimer's and Other Neurodegenerative Diseases: The Prospect of the Eye as a Tool for the Early Diagnosis of Alzheimer's Disease

TLDR
The visual abnormalities of Alzheimer's and other neurodegenerative diseases are discussed, focused on ocular functional-visual-structural biomarkers, retinal pathology, and potential novel diagnostic tools.

Using cerebrospinal fluid marker profiles in clinical diagnosis of dementia with Lewy bodies, Parkinson's disease, and Alzheimer's disease.

TLDR
It is concluded that DLB can be distinguished from PD, in spite of both being synucleinopathies, by CSF profiles using neurodegenerative marker analysis.
...

References

SHOWING 1-10 OF 247 REFERENCES

Molecular genetics of Alzheimer’s disease

TLDR
Evidence is shown that Alzheimer’s disease is a genetically heterogeneous disorder, and new approaches are delineated in the study of the etiological and pathogenetic mechanisms of Alzheimer's disease.

Alzheimer's disease: genes, proteins, and therapy.

TLDR
Evidence that the presenilin proteins, mutations in which cause the most aggressive form of inherited AD, lead to altered intramembranous cleavage of the beta-amyloid precursor protein by the protease called gamma-secretase has spurred progress toward novel therapeutics and provided discrete biochemical targets for drug screening and development.

Age, neuropathology, and dementia.

TLDR
The association between the pathological features of Alzheimer's disease and dementia is stronger in younger old persons than in older old persons, and age must be taken into account when assessing the likely effect of interventions against dementia on the population.

Amyloid Angiopathy–Related Vascular Cognitive Impairment

TLDR
Data from patients with CAA-related intracerebral hemorrhage suggesting associations of CAA with radiographic white matter abnormalities and cognitive impairment highlight the importance of elucidating the effects of vascular amyloid on cerebrovascular function and of developing therapeutic strategies for this potentially widespread form of microvascular cognitive impairment.

How common are the “common” neurologic disorders?

TLDR
Using the best available data, a survey of a limited number of disorders shows that the burden of neurologic illness affects many millions of people in the United States.

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

TLDR
Both linear regressions and multivariate analyses correlating three global neuropsychological tests with a number of structural and neurochemical measurements performed on a prospective series of patients with Alzheimer's disease and 9 neuropathologically normal subjects reveal very powerful correlations with all three psychological assays.

Atherosclerosis of Cerebral Arteries in Alzheimer Disease

TLDR
It is hypothesized that AD pathology is the complex end result of slowly evolving vascular disease and parenchymal lesions and important treatment options and directions for additional interventions to stave off this dementia are suggested.

Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity

TLDR
The loss of neuronal connectivity, indexed by loss of synapses, predicted the degree of cognitive impairment in the patients who underwent biopsy and indicated a degree of structural change in AD brain not likely to be affected by pharmacotherapy.

National Institute of Neurological Disorders and Stroke FIVE-YEAR STRATEGIC PLAN ON MINORITY HEALTH DISPARITIES

TLDR
The NINDS has scientific interests in neurological disorders as diverse as stroke, epilepsy, multiple sclerosis, head and spinal cord injuries, Alzheimer's disease and other dementias, Parkinson's disease, neurofibromatosis, muscular dystrophy, neuroAIDS, amyotrophic lateral sclerosis, and Huntington disease.
...